
Release date: 2026-01-08 11:54:52 Article From: Lucius Laos Recommended: 330
Trametinib (Mekinist) is a targeted therapy indicated for the treatment of unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations. As a prescription-only medication, its purchase and administration must be strictly in accordance with medical guidance.
(1) Patients may choose to consult and purchase the drug at hospital pharmacies or licensed retail pharmacies in countries/regions where trametinib has been approved for marketing.
(2) Given that drug prices may be affected by factors such as regional variations and exchange rate fluctuations, patients are advised to make a budget and plan in advance before purchasing.
(1) Patients can consult domestic overseas medical service institutions that have partnerships with international pharmacies or pharmaceutical manufacturers.
(2) These institutions typically offer legitimate import channels and provide professional consultation and guidance services.
(1) Trametinib is a strictly prescription-only drug and must not be purchased without a valid prescription.
(2) Prior to medication initiation, a specialist physician must confirm the presence of BRAF V600E or V600K mutations using an FDA-approved testing method (e.g., THxID™ BRAF Test) and assess that the patient’s physical condition is suitable for treatment with this drug.
(1) At the time of purchase, carefully verify that the key information on the drug packaging is consistent with the details specified in the doctor’s prescription.
(2) Such information includes: the generic name (Trametinib), brand name (Mekinist), dosage strength (e.g., 2 mg), manufacturer (GlaxoSmithKline), and expiration date.
(1) Official Markings: Check for clear manufacturer information (GlaxoSmithKline), brand logo (Mekinist™), and anti-counterfeiting labels.
(2) Print Quality: Authentic packaging features high-quality printing with clear fonts and uniform colors. Counterfeit products often exhibit blurred printing, color deviations, or spelling errors.
(3) Traceability Information: Verify the presence of clearly printed and retrievable batch number, expiration date, and drug traceability code (if applicable).
(1) 0.5 mg tablet: Yellow, modified oval-shaped, biconvex, with “GS” engraved on one side and “TFC” on the other.
(2) 1 mg tablet: White, round, biconvex, with “GS” engraved on one side and “LHE” on the other.
(3) 2 mg tablet: Pink, round, biconvex, with “GS” engraved on one side and “HMI” on the other.
(4) Upon receiving the medication, compare the tablet color, shape, and engravings against the official descriptions above to ensure full consistency.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended:[list:visits]2026-30-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643